AC Castellan, M Tod, F Gueyffier, M Audars… - Clinical …, 2013 - hero.epa.gov
BACKGROUND AND OBJECTIVE: Cytochrome P450 (CYP) 2C9 is the most common CYP2C enzyme and makes up approximately onethird of total CYP protein content in the …
AC Castellan, M Tod, F Gueyffier, M Audars… - Clinical …, 2013 - cir.nii.ac.jp
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure | CiNii Research CiNii 国立情報学研究所 学術情報 …
AC Castellan, M Tod, F Gueyffier, M Audars… - Clinical …, 2013 - infona.pl
Background and Objective Cytochrome P450 (CYP) 2C9 is the most common CYP2C enzyme and makes up approximately onethird of total CYP protein content in the liver. It …
AC Castellan, M Tod, F Gueyffier… - Clinical …, 2013 - search.proquest.com
Abstract Cytochrome P450 (CYP) 2C9 is the most common CYP2C enzyme and makes up approximately onethird of total CYP protein content in the liver. It metabolises more than 100 …
AC Castellan, M Tod, F Gueyffier… - Clinical …, 2013 - univ-lyon1.hal.science
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure - Université Claude Bernard Lyon 1 Accéder …
AC Castellan, M Tod, F Gueyffier… - Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
Background and objective Cytochrome P450 (CYP) 2C9 is the most common CYP2C enzyme and makes up approximately onethird of total CYP protein content in the liver. It …
AC Castellan, M Tod, F Gueyffier, M Audars… - Clinical …, 2013 - hal.science
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure - Archive ouverte HAL Accéder directement au …
AC Castellan, M Tod, F Gueyffier… - Clinical …, 2013 - search.ebscohost.com
Abstract Background and Objective: Cytochrome P450 (CYP) 2C9 is the most common CYP2C enzyme and makes up approximately onethird of total CYP protein content in the …
AC Castellan, M Tod, F Gueyffier, M Audars… - Clinical …, 2013 - europepmc.org
Methods We created two models. The genetic model was designed to predict the impact of CYP2C9 polymorphisms on drug exposure. It links the area under the concentration-time …